Aspirin could help prevent hearing loss in cancer patients. Deafness is a common side effect of people undergoing chemotherapy. Sally Simmonds met a Hampshire patient to hear her views.
Wendy Hedge says a new trial investigating whether high doses of aspirin can help prevent permanent hearing loss in cancer patients will make a huge difference to lives. It's a common side effect for those taking the chemotherapy drug cisplatin, which is given to 20-thousand people a year.
A new trial investigating whether high doses of aspirin can help prevent permanent hearing loss is being launched in Southampton today. Hearing loss is a common side effect for cancer patients taking the chemotherapy drug cisplatin.
The trial is looking for patients who have been prescribed the drug at hospitals in Southampton Bournemouth and Poole.
Half of the patients will be given 4 daily doses of high-dose aspirin each time they receive the standard cisplatin treatment.
The remainder will be treated with a placebo for the same four days, with their cisplatin. All patients will be given a hearing test just before starting their treatment and at one week and three months thereafter.